Jun 21, 2026 05:00PM
Jun 21, 2026 05:00PM
May 12, 2026 07:14AM
May 11, 2026 07:12AM
May 10, 2026 09:00AM
May 10, 2026 09:00AM
May 10, 2026 09:00AM MoonLake gets FDA alignment for hidradenitis suppurativa drug filing
May 10, 2026 09:00AM
May 10, 2026 09:00AM
Mar 19, 2026 03:42AM
Feb 22, 2026 11:00AM
Feb 22, 2026 11:00AM
Feb 3, 2026 06:45AM
Feb 2, 2026 08:00AM MoonLake receives FDA fast track designation for sonelokimab PPP treatment
Feb 2, 2026 08:00AM
Jan 15, 2026 02:26AM
Jan 9, 2026 05:51AM
Jan 8, 2026 09:32AM
Jan 8, 2026 08:51AM
Jan 8, 2026 08:05AM
Jan 8, 2026 08:00AM MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day
Nov 5, 2025 07:00AM
Sep 29, 2025 06:56AM
Sep 28, 2025 12:05PM
Sep 28, 2025 12:04PM
Sep 11, 2025 08:18AM
Aug 5, 2025 07:00AM
Aug 5, 2025 05:40AM Clear Street Reiterates Buy Rating on Moonlake Immunotherapeutics (MLTX)
May 12, 2025 04:00PM
Apr 25, 2025 04:05PM
Apr 12, 2025 04:00AM
Feb 26, 2025 07:00AM
Nov 7, 2024 07:00AM
Sep 9, 2024 07:00AM
Aug 7, 2024 08:00AM MoonLake Immunotherapeutics Reports Second Quarter 2024 Financial Results and Announces a Capital Markets Update for September 11
Jun 10, 2024 08:00AM
Jun 10, 2024 07:02AM
May 7, 2024 08:00AM
Mar 10, 2024 12:00PM
Feb 29, 2024 08:00AM
Feb 29, 2024 08:00AM
Feb 26, 2024 08:02AM MoonLake Immunotherapeutics (MLTX) Reports Positive Feedback from FDA and EMA on Regulatory Path for Phase 3 Program of sonelokimab
Feb 26, 2024 08:00AM
Nov 14, 2023 08:00AM
Oct 15, 2023 09:03AM
Aug 10, 2023 07:00AM
Nov 14, 2022 08:00AM
Nov 14, 2022 08:00AM
Sep 26, 2022 08:17AM MoonLake Immunotherapeutics (MLTX) to initiate global Phase 2 study of the Nanobody® sonelokimab in patients with active psoriatic arthritis
Sep 26, 2022 08:00AM

323,579 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All